Lipoprotein(a) as an Unmodifiable Risk Marker in a Modifiable Risk World: Testing, Interpretation and Communication. Journal of Heart and Cardiovascular Science, [S. l.], v. 2, n. 1, p. 14–19, 2021. DOI: 10.5281/zenodo.22305492. Disponível em: https://pragmajournals.org/index.php/JHCS/article/view/160. Acesso em: 30 oct. 2026.